Otwarty dostęp

Evaluation of the Early Results of Percutaneous Ethanol Ablation in Patients with Primary Hyperparathyroidism


Zacytuj

1. Wermers RA, Khosla S, Аtkinson EJ, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J. Bone Miner Res 2006; 21(1):171-7.10.1359/JBMR.05091016355286 Search in Google Scholar

2. Udelsman R Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 2002; 235(5):665-670.10.1097/00000658-200205000-00008142249211981212 Search in Google Scholar

3. Udelsman R, Lin Z, Donovan P. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg 2011; 253(3):585-591.10.1097/SLA.0b013e318208fed921183844 Search in Google Scholar

4. Thomas DC, Roman SA, Sosa JA. Parathyroidectomy in the elderly: analysis of 7313 patients. J Surg Res 2011; 170:240-246.10.1016/j.jss.2011.03.01421571309 Search in Google Scholar

5. Iñiguez-Ariza NM, Lee RA, Singh-Ospina NM, et al. Ethanol Ablation for the Treatment of Cystic and Predominantly Cystic Thyroid Nodules. Mayo Clin Proc. 2018; 93(8):1009-1017.10.1016/j.mayocp.2018.05.02030078409 Search in Google Scholar

6. Sharma A, Abraham D. Vascularity targeted percutaneous ethanol injection of toxic adenomas: outcomes of a feasibility study performed in the USA. Endocr Pract. 2020; 26(1):22-29.10.4158/EP-2019-032931461356 Search in Google Scholar

7. Hay ID, Lee RA, Kaggal S, et al. Long-term results of treating with ethanol ablation 15 adult patients with cT1aN0 papillary thyroid microcarcinoma, J Endocr. Soc. 2020; 4(11):1-9. Search in Google Scholar

8. Bhatti AH, Sheikh AE, Mahmud US, et. al. Clinical profile and treatment of hepatocellular carcinoma: A single-center experience. South Asian J Cancer 2021; 10:76-80.10.1055/s-0041-1729451846034134568219 Search in Google Scholar

9. Solbiati L, Giangrande A, De-Pra L, et al. Percutaneous ethanol injection of parathyroid tumours under US guidance: treatment of secondary hyperthyroidism. Radiol 1985; 155:607-10.10.1148/radiology.155.3.38899993889999 Search in Google Scholar

10. Kovatcheva R, Borissova A-M, Kanev N, et al. Ultrasoundguided percutaneous sclerosing of parathyroid glands - an alternative to complex treatment of secondary hyperparathyroidism. Rеntgenologiya I Radiologiya 1994; 33(4):33. Search in Google Scholar

11. Fletcher S, Kanagasundaram NS, Rayner HC, et al. Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism. Nephrol Dial Transplant 1998; 13:3111-3117.10.1093/ndt/13.12.31119870475 Search in Google Scholar

12. Koiwa F, Kakuta T, Tanaka R, Yumita S. Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism. Nephrol Dial Transplant 2007; 22:522-8.10.1093/ndt/gfl62017127701 Search in Google Scholar

13. Charboneau JW, Hay ID, Van Heerden JA. Persistent primary hyperparathyroidism: successful ultrasound-guided percutaneous ethanol ablation of an occult adenoma. Mayo Clin Proc 1988; 63:913-7.10.1016/S0025-6196(12)62695-0 Search in Google Scholar

14. Harman CR, Grant CS, Hay ID, et al. Indications, technique, and efficacy of alcohol injection of enlarged parathyroid glands in patients with primary hyperparathyroidism. Surgery 1998; 124:1011-9.10.1067/msy.1998.91826 Search in Google Scholar

15. Kovatcheva R, Vlahov J, Shinkov A, et al. High-intensity focused ultrasound to treat primary hyperparathyroidism: A feasibility study in four patients. Am J Roentgenol, 2010, 195(4): 830-835.10.2214/AJR.09.3932 Search in Google Scholar

16. Kovatcheva R, Vlahov J, Stoinov J, et al. US-guided highintensity focused ultrasound as a promising non-invasive method for treatment of primary hyperparathyroidism. Eur Radiol, 2014, 24(9): 2052-2058.10.1007/s00330-014-3252-4 Search in Google Scholar

17. Fan BQ, He XW, Chen HH, Zhang WM, Tang W. US-guided microwave ablation for primary hyperparathyroidism: a safety and efficacy study. Eur Radiol, 2019; 29 (10):5607-5616.10.1007/s00330-019-06078-y Search in Google Scholar

18. Kim BS, Eom TI, Kang KH, Park SJ. Radiofrequency ablation of parathyroid adenoma in primary hyperparathyroidism. J Med Ultrason, 2014; 41(2):239-43.10.1007/s10396-013-0501-0 Search in Google Scholar

19. Cercueil JP, Jacob D, Verges B, et al. Percutaneous ethanol injection into parathyroid adenomas: Mid and longterm results. Eur Radiol 1998; 8:15659.10.1007/s003300050587 Search in Google Scholar

20. Stratigis S, Stylianou K, Mamalaki E, et al. Percutaneous ethanol injection therapy: a surgery-sparing treatment for primary hyperparathyroidism. Clin Endocrinol (Oxf) 2008; 69:542-8.10.1111/j.1365-2265.2008.03238.x Search in Google Scholar

21. Yazdani АА, Khalili N, Siavash M, et al. Ultrasoundguided ethanol injection for the treatment of parathyroid adenoma: A prospective selfcontrolled study, J Res Med Sci 2020; 25:93. Search in Google Scholar

22. Chen HH, Hsu MT, Wu CJ, et al. Effects of percutaneous ethanol injection therapy on subsequent parathyroidectomy. Am J Surg 2008;196:155-9.10.1016/j.amjsurg.2007.06.037 Search in Google Scholar

23. Verges B, Cercueil JP, Pfitzenmeyer P, et al. Percutaneous ethanol injection of parathyroid adenomas in primary hyperparathyroidism. Lancet 1991; 337: 1421-2.10.1016/0140-6736(91)93115-P Search in Google Scholar

24. Karstrup S, Transbol I, Holm H, et al. Ultrasound-guided chemical parathyroidectomy in patients with primary hyperthyroidism: a prospective study. Br J Radiol 1989; 62 1037-42.10.1259/0007-1285-62-744-10372691006 Search in Google Scholar

25. Veldman MW, Reading CC, Farrell MA, et al. Percutaneous parathyroid ethanol ablation in patients with multiple endocrine neoplasia type 1. Am J Roentgenol 2008; 191:1740–4.10.2214/AJR.07.343119020245 Search in Google Scholar

26. Cappelli C, Pelizzari G, Pirola I, et al. Modified percutaneous ethanol injection of parathyroid adenoma in primary hyperparathyroidism. QJM 2008; 101(8):657-62.10.1093/qjmed/hcn06218499732 Search in Google Scholar

eISSN:
2719-5384
Język:
Angielski
Częstotliwość wydawania:
4 razy w roku
Dziedziny czasopisma:
Medicine, Basic Medical Science, Immunology, Clinical Medicine, other